Ablation Devices Market Global Opportunity Analysis and Industry Forecast, 2014 - 2022
Introduction
• Ablation is a minimally invasive procedure that treats various chronic diseases such as cancer and pulmonary conditions, as well as used for aesthetic procedures.
• The market is expected to grow at a significant rate due to various advantages of ablation procedures (short time duration, minimized blood loss and damage to healthy organs and tissues, operator friendly) over conventional methods such as chemotherapy, as it has high side-effects.
Current and Future Market Scenario • Global Ablation Device Market was $3,047 million in 2015 and is estimated to reach $6,658 million by 2022 • Ablation Device Market is growing at a CAGR of 11.7% from 2016 to 2022 • Turkey ablation devices market is projected to grow at a high CAGR of 10.8% during the forecast period. • In the year 2015, cancer segment held the majority of the market share due to increase in the number of cancer patients and high precision of ablation techniques to destroy cancer cells.
Factors Contributing to Market Growth • The introduction of innovative and advanced ablation technologies and the increase in the prevalence of chronic diseases and awareness about the procedure would contribute towards the market growth.
Other factors that contribute to market growth are: • Rise in the prevalence of chronic illnesses • Technological advancements
• Short duration and high efficacy of the procedure
Market Segments
Technology
Application
• • • • • •
• • • • • •
Electrical Radiation Radiofrequency Ultrasound Microwave Hydrothermal
Cancer Cardiovascular Ophthalmology Gynecology Urology Orthopedics
Function
Procedure
• Automated/Robotic • Conventional
• • • • •
Aesthetics-Skin Rejuvenation and Tightening Benign Prostatic Hyperplasia Transurethral Needle Ablation Stress Urinary Incontinence Menorrhagia/Endometrial Ablation
Dominating Segments • Thermal ablation devices segment is estimated to dominate the market throughout the analysis period. • Thermal segment dominated the world ablation devices market in 2015 and is expected to continue with its dominance throughout the forecast period. • With the robotic ablation devices, the procedure can be conducted with miniaturization, precision, and smaller incisions. Hence, it is expected to be the fastest growing function segment. However, this technique is relatively new and expensive as compared to the conventional methods. Therefore, currently conventional ablation devices is the dominant segment in the ablation device market.
Region Overview • North America and Europe have the highest growth potential due to established reimbursement policies, high buying power, rapid adoption of minimal-invasive therapies, rise in the count of aging population, and increasing prevalence of patients with chronic illnesses.
• However, the market would gain traction in the developing regions of Asia-Pacific and Latin America as well, due to the increase in urbanization & disposable income, large number of undiagnosed patients, and growing awareness about ablation devices.
Leading Players • Acquisition is another key strategy that has been adopted by key companies. Due to the presence of numerous small-sized to mid-sized companies, the larger companies acquire smaller and emergent companies to curb the competition and increase their revenue.
• The key players in this industry are Boston Scientific Corporation, AngioDynamics, Inc., AtriCure, Inc., St. Jude Medical, Inc., Medtronic plc, Conmed Corporation, Olympus Corporation, Johnson & Johnson, Smith & Nephew plc, and BTG plc.
Thank You!
For More Details Visit us at https://www.alliedmarketresearch.com/ablation-devices-market
Follow Us On